个性化医疗的全球市场

Personalized Medicines

出版日期: 2023年01月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 216 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

个性化医疗的全球市场2030年将达到7,403亿美元

在COVID-19后改变的商务环境中，2022年5080亿美元的个性化医疗的全球市场在2030年前将修正达到7403亿美元的规模，在分析期间2022-2030年间将以4.8％的年复合成长率增长。本报告所分析的市场区隔之一的个性化营养与健康将记录年复合成长率4.6％，到分析期间结束时将达到4,379亿美元。考虑疫情后的復苏，个人化医疗领域在今后8年的年复合成长率将修正为5.2％。

美国市场估算为1,486亿美元，中国预测将以年复合成长率4.5％增长。

美国的个性化医疗市场在2022年为成为1,486亿美元。作为世界第2大经济大国的中国，在2022年到2030年间年复合成长率将为4.5％，在2030年前将修正达到1,303亿美元的市场规模。其他热门的地区市场有日本和加拿大，从2022年到2030各将以4.3％和4％的速度成长。在欧洲市场中，德国以年复合成长率3.7％成长。

调查对像企业范例

Abbott Molecular
Beckman Coulter, Inc.
bioMerieux SA
Bristol-Myers Squibb Company
Dako Denmark A/S
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Hologic, Inc.
Lab 21 Limited
Macrogen, Inc.
NeoGenomics Laboratories, Inc.
Novartis AG
QIAGEN NV
Rosetta Genomics Ltd.
Thermo Fischer Scientific Inc.

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Personalized Medicines Market to Reach $740.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Personalized Medicines estimated at US$508 Billion in the year 2022, is projected to reach a revised size of US$740.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$437.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Personalized Medical Care segment is readjusted to a revised 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $148.6 Billion, While China is Forecast to Grow at 4.5% CAGR

The Personalized Medicines market in the U.S. is estimated at US$148.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$130.3 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 87 Featured):

Abbott Molecular
Beckman Coulter, Inc.
bioMerieux SA
Bristol-Myers Squibb Company
Dako Denmark A/S
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Hologic, Inc.
Lab 21 Limited
Macrogen, Inc.
NeoGenomics Laboratories, Inc.
Novartis AG
QIAGEN NV
Rosetta Genomics Ltd.
Thermo Fischer Scientific Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Access to Valuable Genetic Information Ushers Transformation in Medicine
- Recent Market Activity
- Market Outlook
- Adoption of Personalized Medicines - A Peek into Developed and Developing Economies
- Increasing Market Availability of Personalized Medicines
- Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
- Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine
- Economics of Personalized Medicine
- Is Emergence of Personalized Medicine Signaling the End of Blockbusters?
- Personalized Medicines - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- Abbott Molecular, Inc. (USA)
- Beckman Coulter Genomics (USA)
- bioMerieux SA (France)
- Bristol-Myers Squibb Company (USA)
- Dako Denmark A/S (Denmark)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- GlaxoSmithKline plc. (UK)
- Hologic, Inc. (USA)
- Lab 21 Limited (UK)
- Macrogen, Inc. (Korea)
- NeoGenomics Laboratories, Inc. (USA)
- Novartis AG (Switzerland)
- QIAGEN NV (The Netherlands)
- Rosetta Genomics Ltd (Israel)
- Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
- Growth Drivers in a Gist
- Key Market Restraints
- Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
- Oncology - A Major Application Market
- Diagnosed Cases of Cancer on the Rise
- World Cancer Statistics: Incidence and Mortality Data
- Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market
- Growing Importance of Personalized Drugs for Cancer Treatment
- Ballooning Global Population Offers Significant Growth Opportunities
- Aging Global Population Drives Personalized Medicines
- Increasing Healthcare Spending in Emerging Markets
- Changing Patients' Trends Drive Personalized Medicine
- Technological Advancements and Consumer Push to Drive Personalized Medicine
- Minimizing Adverse Events - A Major Benefit of Personalized Medicines
- Personalized Medicines Brings Disease Prevention Closer to Reality
- Ability to Manage Healthcare Costs Piques Industry and Government Alike
- Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit
- Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines
- Genomics to Dictate Advancement of Personalized Medicines
- Companion Diagnostics Drive Personalized Medicine
- Biomarkers as Companion Diagnostics
- Personalized Medicines Help Reducing R&D Costs
- Personalized Medicine - A Corporate Growth Strategy
- Development Pipeline Reveals Promising Picture for Personalized Medicine
- Advancements in Biomedical Imaging to Enhance Personalized Medicines
- Increasing Use of Personalized Medicines Drives Genetic Testing
- Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
- Next-Generation Sequencing - A Giant Leap in Genome Sequencing
- Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine
- Personalized Medicine Goes Beyond DNA Analysis
- Combination Approaches May Mark Future Endeavors
- Need for New Designs in Clinical Trials Emerges in Therapies for Rare Cancers
- Immunotherapy for Cancers - A Potential Breakthrough in the Sector
- Personalized Medicine Industry - Inundated with Data
- Advanced Computing Technologies - The Need of The Hour to Analyze Large Data
- Artificial Intelligence Revolutionizing Personalized Medicine
- Challenges Aplenty for Precision Medicine
- Lack of Clinically Useful Diagnostic Tests - Growth Dampener
- Pricing and Value Dilemma Haunts Personalized Medicines
- Bedside Biopharmaceutical Production to Dramatically Reduce Cost of Personalized Medicine
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 2: World Historic Review for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 3: World 18-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 5: World Historic Review for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 6: World 18-Year Perspective for Personalized Nutrition & Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 8: World Historic Review for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 9: World 18-Year Perspective for Personalized Medical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 11: World Historic Review for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 12: World 18-Year Perspective for Personalized Medicine Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 14: World Historic Review for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 15: World 18-Year Perspective for Personalized Medicine Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- TABLE 16: World Personalized Medicines Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 19: USA 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
CANADA
- TABLE 20: Canada Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 21: Canada Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 22: Canada 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
JAPAN
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 23: Japan Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 24: Japan Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 25: Japan 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
CHINA
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 26: China Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 27: China Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 28: China 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
EUROPE
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 29: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 30: Europe Historic Review for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 31: Europe 18-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
- TABLE 32: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 33: Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 34: Europe 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
FRANCE
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 35: France Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 36: France Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 37: France 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
GERMANY
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 38: Germany Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 39: Germany Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 40: Germany 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
ITALY
- TABLE 41: Italy Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 42: Italy Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 43: Italy 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
UNITED KINGDOM
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 44: UK Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 45: UK Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 46: UK 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 49: Rest of Europe 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
ASIA-PACIFIC
- Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 52: Asia-Pacific 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
REST OF WORLD
- TABLE 53: Rest of World Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 54: Rest of World Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 55: Rest of World 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030